Probe | Locus(GRCh37) | Gene | Region | p-val | Trait | PubMed ID |
cg01748082 | chr9:137772580 | FCN2 | 2.900e-8 | Smoking | 27651444 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
COLCA2 | 0.636 |
PAPLN | 0.626 |
ERBB2 | 0.616 |
PIK3IP1 | 0.6 |
TTLL6 | 0.599 |
NEK8 | 0.593 |
CPT2 | 0.591 |
ALDH1L1 | 0.591 |
WLS | 0.588 |
EHHADH | 0.585 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
DUSP27 | -0.34 |
VIT | -0.31 |
KLRG1 | -0.307 |
FAM19A4 | -0.303 |
CRH | -0.297 |
FIBCD1 | -0.292 |
VGF | -0.287 |
LAMB3 | -0.287 |
FLRT1 | -0.286 |
SMIM18 | -0.284 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FCN2 mRNA" | 23146750 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of FCN2 mRNA | 22230336 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of FCN2 mRNA | 22100608 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of FCN2 mRNA | 21298039 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FCN2 mRNA | 22316170 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of FCN2 mRNA | 26472689 |
C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased expression of FCN2 protein | 28596144 |
D003976 | Diazinon | Diazinon results in increased methylation of FCN2 gene | 22964155 |
D008727 | Methotrexate | Methotrexate results in increased expression of FCN2 mRNA | 24449571 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of FCN2 gene | 29154799 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003823 | antigen binding | - | IDA | 8576206 |
GO:0004252 | serine-type endopeptidase activity | - | TAS | - |
GO:0005515 | protein binding | - | IPI | 19632990 21054788 21490156 |
GO:0043394 | proteoglycan binding | - | IDA | 8576206 |
GO:0046872 | metal ion binding | - | IEA | - |
GO:0048306 | calcium-dependent protein binding | - | IPI | 12421953 |
GO:2001065 | mannan binding | - | IDA | 8576206 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001867 | complement activation, lectin pathway | - | IDA | 14707097 15804047 |
GO:0001867 | complement activation, lectin pathway | - | TAS | - |
GO:0006508 | proteolysis | - | IEA | - |
GO:0006956 | complement activation | - | TAS | - |
GO:0008228 | opsonization | - | IDA | 8576206 |
GO:0043654 | recognition of apoptotic cell | - | IDA | 15804047 |
GO:0050829 | defense response to Gram-negative bacterium | - | IDA | 8576206 |
GO:0050830 | defense response to Gram-positive bacterium | - | IDA | 14707097 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005576 | extracellular region | - | TAS | - |
GO:0005581 | collagen trimer | - | IEA | - |
GO:0070062 | extracellular exosome | - | HDA | 19056867 |
GO:0072562 | blood microparticle | - | HDA | 22516433 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-166658 | Complement cascade | TAS |
R-HSA-166662 | Lectin pathway of complement activation | TAS |
R-HSA-166663 | Initial triggering of complement | TAS |
R-HSA-166786 | Creation of C4 and C2 activators | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-2855086 | Ficolins bind to repetitive carbohydrate structures on the target cell surface | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
27490795 | Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. (2016) | Ashley SL | PLoS One |